Location
Moultrie, GA
Start Date
10-5-2021 12:00 AM
End Date
13-5-2021 12:00 AM
Description
Background: Reducing unnecessary hospital admission/ER visits on HMO/MSO/ACO patients is very challenging beyond traditional 30-90 day readmission threshold. Our study focused on expanding an Interreality (On-Site & On-Line) Care (IC) model (EHJ 2018;39:S225) in high-risk patients in an HMO setting.
Methods: IC model was created by integrating: 1. On-Site Care: ARNP & testing at patients’ residency; 2. On-Line Care: 24/7 monitoring & specialty cardiology/pulmonary intervention; and 3. A new high-risk care system with telemedicine, device, monitoring, protocols & management. A group of 57 Medicare Advantage patients with multiple admission/ER visits from 3 different healthcare organizations were referred to a MSO due to their increased diagnosis severity (CHF/COPD) & costs. Of the 57 patients, 11 patients were lost to follow-up prior to enrollment (n=46). Baseline admission/ER visits were determined on conventional care provided prior to enrollment. Of the 46 enrolled patients, admission/ER visits were normalized by total days of baseline and compared between conventional care (CC) and IC. Patients in IC were treated and followed on average for 70 days (70 ± 33 days).
Results: Prior to IC, patients with CC had 277 total admission/ER visits compared to 14 during IC. Of the 46 enrolled patients, IC showed a 80% decrease for ALL admission/ER visits compared to CC (0.3 ± 0.9 IC vs. 1.5 ± 1.2 CC; p < 0.001) with a decrease in average length of stay of 5.3 days per admission (5.8 ± 5.0 CC vs. 0.5 ± 1.7 IC; p < 0.001).
Conclusions: To our knowledge, this is the 1st study to evaluate and show the possible benefits of IC on reducing admission/ER visits for high-risk (CHF/COPD) patients in the HMO setting. Compared to conventional analytical and administrative models for unnecessary admissions, integrating new technologies to treat high-risk patients may deliver significant clinical benefits to healthcare in the 30-90 day setting.
Embargo Period
6-3-2021
30-90 day benefit of using interreality care to reduce unnecessary hospital admissions among high-risk patients
Moultrie, GA
Background: Reducing unnecessary hospital admission/ER visits on HMO/MSO/ACO patients is very challenging beyond traditional 30-90 day readmission threshold. Our study focused on expanding an Interreality (On-Site & On-Line) Care (IC) model (EHJ 2018;39:S225) in high-risk patients in an HMO setting.
Methods: IC model was created by integrating: 1. On-Site Care: ARNP & testing at patients’ residency; 2. On-Line Care: 24/7 monitoring & specialty cardiology/pulmonary intervention; and 3. A new high-risk care system with telemedicine, device, monitoring, protocols & management. A group of 57 Medicare Advantage patients with multiple admission/ER visits from 3 different healthcare organizations were referred to a MSO due to their increased diagnosis severity (CHF/COPD) & costs. Of the 57 patients, 11 patients were lost to follow-up prior to enrollment (n=46). Baseline admission/ER visits were determined on conventional care provided prior to enrollment. Of the 46 enrolled patients, admission/ER visits were normalized by total days of baseline and compared between conventional care (CC) and IC. Patients in IC were treated and followed on average for 70 days (70 ± 33 days).
Results: Prior to IC, patients with CC had 277 total admission/ER visits compared to 14 during IC. Of the 46 enrolled patients, IC showed a 80% decrease for ALL admission/ER visits compared to CC (0.3 ± 0.9 IC vs. 1.5 ± 1.2 CC; p < 0.001) with a decrease in average length of stay of 5.3 days per admission (5.8 ± 5.0 CC vs. 0.5 ± 1.7 IC; p < 0.001).
Conclusions: To our knowledge, this is the 1st study to evaluate and show the possible benefits of IC on reducing admission/ER visits for high-risk (CHF/COPD) patients in the HMO setting. Compared to conventional analytical and administrative models for unnecessary admissions, integrating new technologies to treat high-risk patients may deliver significant clinical benefits to healthcare in the 30-90 day setting.